Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Other Non-Current Assets (2020 - 2026)

Privia Health has reported Other Non-Current Assets over the past 6 years, most recently at $21.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 23.17% year-over-year to $21.0 million; the TTM value through Dec 2025 reached $21.0 million, up 23.17%, while the annual FY2025 figure was $21.0 million, 23.17% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $21.0 million at Privia Health, up from $16.9 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $21.0 million in Q4 2025 and troughed at $3.1 million in Q2 2022.
  • A 5-year average of $9.5 million and a median of $6.4 million in 2021 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 43.92% in 2022 and later surged 229.23% in 2024.
  • Year by year, Other Non-Current Assets stood at $4.5 million in 2021, then increased by 3.58% to $4.7 million in 2022, then skyrocketed by 83.22% to $8.6 million in 2023, then surged by 99.13% to $17.1 million in 2024, then increased by 23.17% to $21.0 million in 2025.
  • Business Quant data shows Other Non-Current Assets for PRVA at $21.0 million in Q4 2025, $16.9 million in Q3 2025, and $16.6 million in Q2 2025.